Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Francesco Zonta has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Topology-Dependent Mechanical Failure of Knotted Polymer Chains from Reactive Molecular Dynamics

    by Zhirui Xiang, Tianhang Zhou, Francesco Zonta, Zhenghao Wu

    Long polymer chains are inevitably tangled in knots that compromise their mechanical strength, yet how knot complexity governs the molecular rupture mechanism remains poorly understood. Here, we study the mechanical failure of single polyethylene chains bearing knots of varying complexity (3–7 crossings) using reactive molecular dynamics simulations across multiple pulling rates. We identify a consistent three-stage failure mechanism comprising entropy-driven tightening, enthalpy-driven tightening, and bond rupture. The breaking force follows a stretched exponential decay with knot complexity, while the elastic modulus grows exponentially; topological confinement therefore plays two competing roles. Analysis of bond-breaking locations indicates a gradual crossover in the failure mechanism: knots with lower minimum crossing number (31, 41) break predominantly at the knot entrance/exit, whereas knots with higher minimum crossing number (71) rupture within the densely packed core. Bond angle analysis shows that the geometric distinction between entrance and core regions diminishes with increasing minimum crossing number, providing a structural rationale for the boundary-to-core shift and demonstrating that knot topology offers a tunable handle on both polymer strength and stiffness.

  • ANUBI: A Platform for Affinity Optimization of Proteins and Peptides in Drug Design

    by Damiano Buratto, Wanding Wang, Xinyi Zhang, Qiujie Zhu, Jia Meng, Daniel J. Rigden, Ruhong Zhou, Francesco Zonta

    The increasing availability of computational power opens unprecedented opportunities in computational biology and drug design. Computer simulations based on physical models can now reproduce or replace critical biophysical experiments, such as binding affinity evaluations in the drug screening process. Here, we present ANUBI (ANUBI Nexus for Understanding Binding Interactions), a software package that automates sequence space exploration and binding free energy calculations to optimize protein or peptide drug candidates for improved target binding. Starting from a user-provided molecular model of the drug-target interaction, ANUBI systematically evaluates point mutations in selected regions using Monte Carlo methodology, retaining favorable mutations based on calculated binding affinity differences. We demonstrate that this approach efficiently samples sequence space, generating dozens of optimized variants in timeframes comparable to experimental approaches at substantially reduced cost. As a proof of concept, we applied ANUBI to an antibody-antigen complex and a peptide-protein interaction, identifying variants with significantly improved predicted binding energy (approximately 20 kcal/mol, calculated using the MMPBSA method), within 20 days of computation on a single GPU.

  • Open Access

    Assessing Computational Strategies for the Evaluation of Antibody Binding Affinities

    by Ida Autiero, Damiano Buratto, Fengyi Guo, Wanding Wang, Malay Ranjan Biswal, Kevin C. Chan, Ruhong Zhou, Francesco Zonta

    Accurate evaluation of binding affinity is critical in drug discovery to identify molecules that bind strongly to their targets while minimizing off-target effects. Although binding affinity calculations are theoretically well defined, they require exhaustive sampling of configurational space, a step that often requires significant computational resources. In this study, we compare different methods for calculating the binding energy of antibodies targeting a peptide derived from the N-terminus of CXCR2, a GPCR-family protein. Contrary to some previous reports, we find that equilibrium molecular mechanics Poisson-Boltzmann surface area (MMPBSA) calculations yield better agreement with experimental binding affinities than nonequilibrium potential of mean force evaluations, underscoring the system-dependent performance of these methods. We also observed a modest improvement in accuracy when MMPBSA is combined with replica exchange molecular dynamics, albeit at a significantly higher computational cost. Calculation based on the Rosetta force field, instead, produced results that did not correlate with the experimental data. We attribute these findings to two factors, which could limit the applicability of some methodologies that are widely used in computing the binding energy: the high potency of the antibodies studied and the dominance of hydrophobic interactions between the antibodies and the peptide. Overall, this work provides important insights for optimizing in silico antibody screening strategies.


  • Open Access

    ANUBI: A Platform for Affinity Optimization of Proteins and Peptides in Drug Design

    by Damiano Buratto, Wanding Wang, Xinyi Zhang, Qiujie Zhu, Jia Meng, Daniel J. Rigden, Ruhong Zhou, Francesco Zonta

    The increasing availability of computational power is opening unprecedented opportunities in computational biology and drug design. Computer simulations based on physical models can now reproduce or replace critical biophysical experiments such as binding affinity evaluations in the drug screening process. Here we present ANUBI (ANUBI Nexus for Understanding Binding Interactions), a software package that automates sequence space exploration and binding free energy calculations to optimize protein or peptide drug candidates for improved target binding. Starting from a user-provided molecular model of the drug-target interaction, ANUBI systematically evaluates point mutations in selected regions using Monte Carlo methodology, retaining favorable mutations based on calculated binding affinity differences. We demonstrate that this approach efficiently samples sequence space, generating dozens of optimized variants in timeframes comparable to experimental approaches at substantially reduced cost. As proof of concept, we applied ANUBI to an antibody-antigen complex and a peptide-protein interaction, identifying variants with significantly improved predicted binding energy (approximately 20 kcal/mol, calculated using the MMPBSA method), within 20 days of computation on a single GPU. Abstract Figure: TOC GRAPHIC:

  • Open Access

    Assessing computational strategies for the evaluation of antibody binding affinities

    by Ida Autiero, Damiano Buratto, Fengyi Guo, Wanding Wang, Malay Ranjan Biswal, Kevin C. Chan, Ruhong Zhou, Francesco Zonta

    Accurate evaluation of binding affinity is critical in drug discovery to identify molecules that bind strongly to their targets while minimizing off-target effects. Although binding affinity calculations are theoretically well-defined, they require exhaustive sampling of configurational space, a step that often requires significant computational resources. In this study, we compare different methods for calculating the binding energy of antibodies targeting a peptide derived from the N-terminus of CXCR2, a GPCR-family protein. Contrary to some previous reports, we find that equilibrium MMPBSA calculations yield better agreement with experimental binding affinities than non-equilibrium potential of mean force evaluations, underscoring the system-dependent performance of these methods. We also observed a modest improvement in accuracy when MMPBSA is combined with replica exchange molecular dynamics, albeit at a significantly higher computational cost. Calculation based on Rosetta force field, instead, produced results that did not correlate with the experimental data. We attribute these findings to two factors, which could limit the applicability of some methodologies that are widely used in the computation the binding energy: the high potency of the antibodies studied and the dominance of hydrophobic interactions between the antibodies and the peptide. Overall, this work provides important insights for optimizing in silico antibody screening strategies.

  • Open Access

    Correction: A fully human IgG1 antibody targeting connexin 32 extracellular domain blocks CMTX1 hemichannel dysfunction in an in vitro model

    by Abraham Tettey-Matey, Viola Donati, Chiara Cimmino, Chiara Di Pietro, Damiano Buratto, Mariateresa Panarelli, Alberto Reale, Arianna Calistri, Maria Vittoria Fornaini, Ruhong Zhou, et al.

  • Open Access

    A fully human IgG1 antibody targeting connexin 32 extracellular domain blocks CMTX1 hemichannel dysfunction in an in vitro model

    by Abraham Tettey-Matey, Viola Donati, Chiara Cimmino, Chiara Di Pietro, Damiano Buratto, Mariateresa Panarelli, Alberto Reale, Arianna Calistri, Maria Vittoria Fornaini, Ruhong Zhou, et al.

    Connexins (Cxs) are fundamental in cell–cell communication, functioning as gap junction channels (GJCs) that facilitate solute exchange between adjacent cells and as hemichannels (HCs) that mediate solute exchange between the cytoplasm and the extracellular environment. Mutations in the GJB1 gene, which encodes Cx32, lead to X-linked Charcot-Marie-Tooth type 1 (CMTX1), a rare hereditary demyelinating disorder of the peripheral nervous system (PNS) without an effective cure or treatment. In Schwann cells, Cx32 HCs are thought to play a role in myelination by enhancing intracellular and intercellular Ca2+ signaling, which is crucial for proper PNS myelination. Single-point mutations (p.S85C, p.D178Y, p.F235C) generate pathological Cx32 HCs characterized by increased permeability (“leaky”) or excessive activity (“hyperactive”).We investigated the effects of abEC1.1-hIgG1, a fully human immunoglobulin G1 (hIgG1) monoclonal antibody, on wild-type (WT) and mutant Cx32D178Y HCs. Using HeLa DH cells conditionally co-expressing Cx and a genetically encoded Ca2+ biosensor (GCaMP6s), we demonstrated that mutant HCs facilitated 58% greater Ca2+ uptake in response to elevated extracellular Ca2+ concentrations ([Ca2+]ex) compared to WT HCs. abEC1.1-hIgG1 dose-dependently inhibited Ca2+ uptake, achieving a 50% inhibitory concentration (EC50) of ~ 10 nM for WT HCs and ~ 80 nM for mutant HCs. Additionally, the antibody suppressed DAPI uptake and ATP release. An atomistic computational model revealed that serine 56 (S56) of the antibody interacts with aspartate 178 (D178) of WT Cx32 HCs, contributing to binding affinity. Despite the p.D178Y mutation weakening this interaction, the antibody maintained binding to the mutant HC epitope at sub-micromolar concentrations.In conclusion, our study shows that abEC1.1-hIgG1 effectively inhibits both WT and mutant Cx32 HCs, highlighting its potential as a therapeutic approach for CMTX1. These findings expand the antibody’s applicability for treating diseases associated with Cx HCs and inform the rational design of next-generation antibodies with enhanced affinity and efficacy against mutant HCs.


  • Molecular Dynamics Simulation of Permeation Through Connexin Channels

    by Francesco Zonta, Fabio Mammano, Sergio Pantano

    Molecular dynamics (MD) simulations are a collection of computational tools that can be used to trace intermolecular interactions at the sub-nanometer level. They offer possibilities that are often unavailable to experimental methods, making MD an ideal complementary technique for the understanding a plethora of biological processes. Thanks to significant efforts by many groups of developers around the world, setting up and running MD simulations has become progressively simpler. However, simulating ionic permeation through membrane channels still presents significant caveats. MD simulations of connexin (Cx) hemichannels (HCs) are particularly problematic because HCs create wide pores in the plasma membrane, and the lateral sizes of the extracellular and intracellular regions are quite different. In this chapter, we provide a detailed instruction to perform MD simulations aimed at computationally modeling the permeation of inorganic ions and larger molecules through Cx HCs. Key words Connexon Free energy barriers Permeation Conduction Pore